Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

PhRMA Uses Allergan Stage In Campaign To Keep Focus On Industry's Reputation For Innovation

Executive Summary

PhRMA CEO Stephen Ubl visited Allergan's Irvine, Calif. R&D and manufacturing campus as the trade association continues its "Go Boldly" campaign promoting biopharma innovation in an effort to counteract the hit the industry's reputation has taken from drug pricing concerns.


Related Content

Why Is Drug Pricing Higher In US? Study Takes Aim At R&D Argument
Allergan’s Ophthalmology Focus Grows Beyond Restasis And Glaucoma
Carrots and Stick: Biopharma At The White House
Pharma's Middlemen Get Fatter: PBM, Health Plan Rebates Near $58bn
Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan
Allergan's Price Reform Pledge: Will Others Follow?
Dealmaking Pays Off For Allergan As Revenue Rises 124% In 2015
Odds-On-Favorite Ubl Confirmed As Next PhRMA CEO
Actavis will become Allergan to emphasize branded pharma focus


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst